查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1748710

電子藥物市場，按產品、按類型、按應用、按國家和地區 - 行業分析、市場規模、市場佔有率及預測（2024 年至 2032 年）

Electroceuticals Market, By Product, By Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 375 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年電子藥物市場規模價值為 224.5645 億美元，從 2024 年到 2032 年的複合年成長率為 7.60%。

電子藥物市場-市場動態

神經系統疾病盛行率上升推動需求

神經系統疾病發生率的不斷上升，大大促進了電療市場的成長。由於人口老化、生活方式的改變以及診斷能力的提高等因素，帕金森氏症、癲癇、慢性憂鬱症、阿茲海默症和多發性硬化症等疾病的盛行率日益上升。這些疾病的治療選擇通常有限，而傳統的藥物療法可能無法達到理想的療效或產生不良副作用。因此，人們越來越傾向於尋求更精準、更少系統性影響的先進治療方案。電療透過電刺激直接作用於引起疾病症狀的神經迴路，提供了一種新穎的治療方法。深部腦部刺激 (DBS)、迷走神經刺激 (VNS) 和脊髓刺激 (SCS) 等技術在治療複雜的神經系統疾病方面已取得顯著成效。由於這些設備在症狀控制和患者生活品質方面取得了更好的效果，它們逐漸受到醫療服務提供者和患者的青睞。

電子藥物市場-關鍵見解

根據我們的研究分析師，全球電子藥物市場預計在 2024 年至 2032 年期間的複合年成長率約為 7.60%。

2023 年按產品細分，心臟節律器和植入式心律轉復除顫器類別佔據了市場主導地位。

根據類型，植入式電療設備在 2023 年產生的收入最多。

按地區分類，2023年北美是收入最高的地區。

電子藥物市場-細分分析：

全球電子藥物市場分為三類：產品、類型、應用和地區。

電療市場按產品細分為心臟節律器和植入式心律轉復除顫器 (ICD)、人工耳蝸、神經調節器和視網膜植入物。其中，心臟心律調節器和ICD預計將佔據市場主導地位。這種主導地位主要源自於全球心血管疾病（包括心律不整和心臟衰竭）的高發生率，這些疾病需要透過心臟電刺激及時介入。這些設備因其療效可靠、技術進步以及在更容易患心臟病的老齡化人群中的日益普及而被廣泛採用。此外，已開發國家的報銷政策以及微創心臟設備的持續創新進一步推動了它們的普及。雖然人工耳蝸和神經調節器是成長型細分市場，但心臟設備長期的臨床應用、強大的基礎設施以及挽救生命的潛力，確保了它們在市場上的領先地位。由於心血管疾病仍然是全球死亡的主要原因，預計對這些設備的需求將保持強勁。

按類型分類，電療市場分為植入式電療設備和非侵入式電療設備。其中，植入式電療設備佔市場主導地位。這種主導地位歸因於其在治療心律不整、癲癇和帕金森氏症等危重慢性疾病的廣泛應用。心臟節律器、植入式心律轉復除顫器 (ICD)、深部腦部刺激器和迷走神經刺激器等裝置提供高效、長期獲益的標靶治療，使其成為治療重症的首選。植入式設備也受益於小型化、電池技術和設備編程的不斷進步，從而提高了其安全性和性能。此外，它們在已開發市場的長期臨床認可和健全的報銷框架支持其更廣泛的應用。儘管非侵入性設備在輕度疾病和家庭治療中越來越受歡迎，但植入式電療因其治療精度和救生應用而繼續引領市場。

電子藥物市場—地理洞察

從地理分佈來看，電子藥物市場遍佈北美、亞太、拉丁美洲、歐洲、中東和非洲。這些地區根據業務開展的國家進一步分類。

北美佔全球電子藥物市場最大佔有率，其中美國是主要貢獻者。該地區受益於強大的醫療基礎設施、高昂的醫療支出以及先進醫療技術的快速普及。帕金森氏症、癲癇、心血管疾病和聽力損失等慢性疾病的盛行率不斷上升，推動了對心臟心律調節器、植入式除顫器 (ICD)、人工耳蝸和深部腦刺激器等植入式裝置的持續需求。此外，美敦力、雅培和波士頓科學等主要市場參與者的存在，確保了強大的研發和商業化管道。美國食品藥物管理局 (FDA) 等監管機構為醫療器材核准提供了明確的框架，促進了創新和市場准入。此外，優惠的報銷政策以及日益增強的醫患意識進一步支持了市場擴張。美國在神經調節和生物電子醫學的臨床試驗和學術研究方面也處於領先地位。加拿大雖然市場規模較小，但也透過公共醫療計劃和增加先進治療的可近性做出了貢獻。隨著該地區繼續投資個人化醫療、數位健康整合和微型生物電子設備，北美預計將在未來幾年保持其在電子藥物領域的領先地位。

歐洲是全球第二大電子藥物市場，其驅動力來自人口老化以及神經系統和心血管疾病發生率的上升。德國、英國和法國等國家憑藉其先進的醫療基礎設施、全面的保險覆蓋和積極的監管支持，成為主要的收入來源。該地區對採用創新治療技術表現出強烈的意願，包括深部腦部刺激、迷走神經刺激和人工耳蝸。歐洲擁有許多致力於生物電子醫學發展的知名學術機構和研究中心。來自公共衛生機構和歐盟的資金支持促進了臨床研究和設備創新的發展。此外，患者對神經調節療法的高度認知和臨床醫生的專業知識也提高了該療法的採用率。許多歐洲國家的報銷框架支持高成本醫療技術的普及，從而提高了患者對電子藥物治療的接受度。

電子藥物市場-競爭格局：

電療市場競爭激烈，美敦力、波士頓科學公司和雅培等老牌醫療器材製造商佔據主導地位，它們憑藉雄厚的研發實力、法規專業知識和全球分銷網路，積極拓展產品組合。這些公司專注於透過心臟器材、神經調節和聽力植入物領域的創新解決方案來拓展產品組合。 LivaNova Plc、Cochlear Ltd. 和 Sonova 專注於迷走神經刺激和人工耳蝸等細分市場，致力於提升神經系統和聽覺障礙患者的治療效果。同時，Axonics Inc.、Neuronetics、ElectroCore Inc. 和 NeuroPace Inc. 等新興企業正透過微創和穿戴式神經調節技術推動創新，這些技術旨在治療憂鬱症、癲癇和膀胱過動症等疾病。微創醫療科學公司和 Nervo Corp. 分別正在亞洲和北美拓展業務。這種競爭格局以策略性收購、合作夥伴關係和持續的產品開發為特徵，創造了一個充滿活力的環境，促進了技術進步和電療療法在全球範圍內的廣泛應用。

最新動態：

2024 年 4 月，Axonics Inc. 宣布 FDA 批准其下一代可充電骶神經調節系統，該系統可提供更長的電池壽命並提高患者的舒適度。

2024 年 1 月，波士頓科學公司收購了專門從事骨內椎基底神經消融治療的公司 Relievant Medsystems，以擴大其慢性疼痛管理產品組合。

2023 年 11 月，雅培的 Eterna(TM) 脊髓刺激系統獲得 CE 標誌認證，該系統採用其最小的可植入可充電神經刺激器，專為緩解慢性疼痛而設計。

2023 年 9 月，Neuronetics 在歐洲新市場推出了 NeuroStar 先進治療系統，擴大了重度憂鬱症患者使用經顱磁刺激 (TMS) 的管道。

目錄

第1章：電子藥物市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 電子藥物市場依產品分類
    • 電子藥物市場片段（按類型）
    • 電子藥物市場片段（按應用）
    • 各國電子藥物市場概況
    • 電療市場按地區細分
  • 競爭洞察

第3章：電子藥物主要市場趨勢

  • 電子藥物市場促進因素
    • 市場促進因素的影響分析
  • 電子藥物市場限制
    • 市場限制的影響分析
  • 電子藥物市場機遇
  • 電子藥物市場未來趨勢

第4章：電子藥物產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：電子藥物市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • 新冠疫情後影響分析
    • 表現最佳的市場區隔
    • 邊際成長細分市場
    • 最鬆散的細分市場
    • 邊際損失市場區隔

第6章：電子藥物市場格局

  • 2023年電子藥物市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：電子藥物市場－依產品分類

  • 概述
    • 按產品細分的市佔率分析
    • 心臟節律器和植入式心律轉復除顫器
    • 人工耳蝸
    • 神經調節劑
      • 脊髓刺激器
      • 深部腦部刺激器
      • 迷走神經刺激器
      • 薦神經刺激器
      • 胃電刺激器
      • 經顱磁刺激器
      • 呼吸電刺激器
      • 三叉神經刺激器
      • 反應性神經刺激器
    • 視網膜植入物

第 8 章：電子藥物市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 植入式電療設備
    • 非侵入性電療設備

第9章：電子藥物市場－按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 心臟節律器和植入式心律轉復除顫器
      • 心律不整
      • 心臟衰竭
      • 其他心臟節律器和ICD應用
    • 脊髓刺激器
      • 慢性疼痛
      • 背部手術失敗綜合症
      • 缺血
    • 深部腦部刺激器
      • 帕金森氏症
      • 震顫
      • 沮喪
      • 其他資料庫應用程式
    • 薦神經刺激器
      • 尿失禁
      • 大便失禁
    • 迷走神經刺激器，
      • 癲癇
      • 其他 Vns 應用
    • 胃電刺激器
      • 胃輕癱
      • 肥胖
    • 經皮神經電刺激器
      • 難治性憂鬱症
      • 其他應用
    • 經顱磁刺激器
      • 沮喪
      • 偏頭痛
    • 呼吸電刺激器
      • 脊髓損傷
    • 三叉神經刺激器
      • 注意力不足過動症
      • 偏頭痛

第 10 章：電子藥物市場 - 按地理分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美電子藥物主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按產品）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲電子藥物主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按產品）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測，按應用
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區電子藥物主要製造商
    • 亞太市場規模及預測（按國家/地區）
    • 亞太市場規模及預測（按產品）
    • 亞太市場規模及預測（按類型）
    • 亞太市場規模及預測（按應用）
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲電子藥物主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按產品）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲的電子藥物主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模和預測（按類型）
    • 中東和非洲市場規模和預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 11 章：電子藥物產業主要供應商分析

  • 競爭儀錶板
  • 公司簡介
    • Medtronic
    • Boston Scientific Corporation
    • Abbott
    • Livanova Plc
    • Cochlear Ltd.
    • Microport Scientific Corporation
    • Sonova
    • Nervo Corp.
    • Axonics Inc.
    • Neuronetics
    • Electrocore Inc.
    • Neuropace Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5243

REPORT HIGHLIGHT

Electroceuticals Market size was valued at USD 22,456.45 Million in 2024, expanding at a CAGR of 7.60% from 2024 to 2032.

Electroceuticals, also known as bioelectronic medicines, are a class of therapeutic devices that use electrical impulses to modulate the body's neural circuits, offering an alternative or complement to pharmaceutical treatments. These devices target specific nerves or brain regions to treat various medical conditions, including chronic pain, epilepsy, Parkinson's disease, depression, and even inflammatory disorders. Unlike traditional pharmaceuticals that rely on chemical interactions within the body, electroceuticals operate by influencing the electrical signaling pathways that underlie physiological processes. Typically, electroceutical devices are either implanted or wearable, depending on the condition being treated. For example, deep brain stimulators, vagus nerve stimulators, and spinal cord stimulators are commonly used implantable electroceuticals. These devices deliver precisely controlled electrical signals to alter abnormal nerve activity, helping to restore normal function or alleviate symptoms. Recent advancements in neuroscience, bioengineering, and miniaturization have driven innovation in this field, enabling more targeted and less invasive treatments. Electroceuticals are considered promising in areas where conventional drug therapies may fall short due to side effects, limited efficacy, or resistance. By harnessing the body's electrical system, electroceuticals open up new possibilities for personalized and precise medical interventions, potentially transforming the way chronic diseases are managed in the future.

Electroceuticals Market- Market Dynamics

Rising Prevalence of Neurological Disorders Driving Demand

The increasing incidence of neurological disorders is significantly contributing to the growth of the electroceuticals market. Conditions such as Parkinson's disease, epilepsy, chronic depression, Alzheimer's disease, and multiple sclerosis are becoming more prevalent due to factors like aging populations, lifestyle changes, and improved diagnostic capabilities. These disorders often have limited treatment options, and conventional pharmaceutical approaches may lead to inadequate results or undesirable side effects. As a result, there is a growing shift toward advanced therapeutic solutions that offer greater precision and fewer systemic impacts. Electroceuticals provide a novel approach by directly targeting neural circuits responsible for disease symptoms through electrical stimulation. Technologies such as deep brain stimulation (DBS), vagus nerve stimulation (VNS), and spinal cord stimulation (SCS) have shown considerable success in managing complex neurological conditions. With better outcomes in symptom control and patient quality of life, these devices are gaining traction among healthcare providers and patients alike.

ELECTROCEUTICALS Market- Key Insights

According to our research analyst, the global Electroceuticals Market is expected to develop at a CAGR of approximately 7.60% between 2024-2032.

Segmented by Product in 2023, the Cardiac Pacemakers & Implantable Cardioverter Defibrillators category dominated the market.

Based on type, the Implantable Electroceutical Devices generated the most income in 2023.

Based on region, in 2023, North America was the region with the highest revenue.

Electroceuticals Market- Segmentation Analysis:

The global Electroceuticals market is divided into three categories: product, type, application and region.

The electroceuticals market is segmented by product into Cardiac Pacemakers & Implantable Cardioverter Defibrillators (ICDs), Cochlear Implants, Neuromodulators, and Retinal Implants. Among these, Cardiac Pacemakers & ICDs are expected to dominate the market. This dominance is primarily driven by the high global prevalence of cardiovascular diseases, including arrhythmias and heart failure, which require timely intervention through electrical stimulation of the heart. These devices are widely adopted due to their proven efficacy, technological advancements, and increasing use in aging populations who are more susceptible to heart conditions. Additionally, the availability of reimbursement policies in developed countries and ongoing innovation in minimally invasive cardiac devices further boost their adoption. While cochlear implants and neuromodulators are growing segments, the long-standing clinical use, robust infrastructure, and life-saving potential of cardiac devices secure their leading position in the market. As cardiovascular diseases remain a leading cause of mortality worldwide, demand for these devices is expected to remain strong.

By type electroceuticals market is segmented into Implantable Electroceutical Devices and Noninvasive Electroceutical Devices. Among these, Implantable Electroceutical Devices hold the dominant share of the market. This dominance is attributed to their widespread application in treating critical, chronic conditions such as cardiac arrhythmias, epilepsy, and Parkinson's disease. Devices like cardiac pacemakers, implantable cardioverter defibrillators (ICDs), deep brain stimulators, and vagus nerve stimulators offer targeted therapy with high efficacy and long-term benefits, making them the preferred choice for severe medical conditions. Implantable devices also benefit from continuous advancements in miniaturization, battery technology, and device programming, which enhance their safety and performance. Furthermore, their long-standing clinical acceptance and robust reimbursement frameworks in developed markets support broader adoption. Although noninvasive devices are gaining traction for mild conditions and home-based therapies, implantable electroceuticals continue to lead the market due to their therapeutic precision and life-saving applications.

Electroceuticals Market- Geographical Insights

Geographically, the Electroceuticals Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America holds the largest share of the global electroceuticals market, with the United States as the primary contributor. The region benefits from a robust healthcare infrastructure, high healthcare spending, and rapid adoption of advanced medical technologies. A rising prevalence of chronic disorders-such as Parkinson's disease, epilepsy, cardiovascular conditions, and hearing loss-drives consistent demand for implantable devices like cardiac pacemakers, ICDs, cochlear implants, and deep brain stimulators. Additionally, the presence of key market players such as Medtronic, Abbott, and Boston Scientific ensures strong research, development, and commercialization pipelines. Regulatory agencies such as the U.S. FDA provide a well-defined framework for medical device approvals, promoting innovation and market entry. Moreover, favorable reimbursement policies and growing physician and patient awareness further support market expansion. The U.S. also leads in clinical trials and academic research focused on neuromodulation and bioelectronic medicine. Canada, while smaller in market size, also contributes through public healthcare initiatives and increased access to advanced treatments. As the region continues to invest in personalized medicine, digital health integration, and miniaturized bioelectronic devices, North America is expected to maintain its leadership in the electroceuticals landscape over the coming years.

Europe stands as the second-largest market for electroceuticals, driven by an aging population and a rising incidence of neurological and cardiovascular disorders. Countries such as Germany, the United Kingdom, and France are major revenue generators due to their advanced healthcare infrastructure, comprehensive insurance coverage, and proactive regulatory support. The region has shown a strong inclination toward adopting innovative therapeutic technologies, including deep brain stimulation, vagus nerve stimulation, and cochlear implants. Europe is home to prominent academic institutions and research centers contributing to bioelectronic medicine development. Funding from both public health bodies and the European Union fosters the growth of clinical research and device innovation. Furthermore, high patient awareness and clinician expertise in neuromodulation therapies bolster adoption rates. Reimbursement frameworks in many European countries support access to high-cost medical technologies, thereby increasing patient uptake of electroceutical treatments.

Electroceuticals Market- Competitive Landscape:

The electroceuticals market is highly competitive, with dominance from established medical device manufacturers such as Medtronic, Boston Scientific Corporation, and Abbott, who leverage extensive R&D capabilities, regulatory expertise, and global distribution networks. These companies focus on expanding their portfolios through innovative solutions in cardiac devices, neuromodulation, and hearing implants. LivaNova Plc, Cochlear Ltd., and Sonova specialize in niche segments like vagus nerve stimulation and cochlear implants, enhancing patient outcomes in neurological and auditory disorders. Meanwhile, emerging players such as Axonics Inc., Neuronetics, ElectroCore Inc., and NeuroPace Inc. are driving innovation through minimally invasive and wearable neuromodulation technologies targeting conditions like depression, epilepsy, and overactive bladder. MicroPort Scientific Corporation and Nervo Corp. are expanding their footprint in Asia and North America, respectively. This competitive landscape, characterized by strategic acquisitions, partnerships, and continuous product development, fosters a dynamic environment that promotes technology advancement and broader adoption of electroceutical therapies worldwide.

Recent Developments:

In April 2024, Axonics Inc. announced FDA approval for its next-generation rechargeable sacral neuromodulation system, offering longer battery life and improved patient comfort.

In January 2024, Boston Scientific Corporation acquired Relievant Medsystems, a company specializing in intraosseous basivertebral nerve ablation therapy, to expand its chronic pain management portfolio.

In November 2023, Abbott received CE Mark approval for its Eterna(TM) spinal cord stimulation system, featuring its smallest implantable rechargeable neurostimulator designed for chronic pain relief.

In September 2023, Neuronetics launched the NeuroStar Advanced Therapy System in new markets across Europe, expanding access to transcranial magnetic stimulation (TMS) for major depressive disorder.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ELECTROCEUTICALS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Livanova Plc
  • Cochlear Ltd.
  • Microport Scientific Corporation
  • Sonova
  • Nervo Corp.
  • Axonics Inc.
  • Neuronetics
  • Electrocore Inc.
  • Neuropace Inc.
  • Others

GLOBAL ELECTROCEUTICALS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Cardiac Pacemakers & Implantable Cardioverter Defibrillators
  • Cochlear Implants
  • Neuromodulators
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Vagus Nerve Stimulators
  • Sacral Nerve Stimulators
  • Gastric Electrical Stimulators
  • Transcranial Magnetic Stimulators
  • Respiratory Electrical Stimulators
  • Trigeminal Nerve Stimulators
  • Responsive Neurostimulators
  • Retinal Implants

GLOBAL ELECTROCEUTICALS MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Implantable Electroceutical Devices
  • Noninvasive Electroceutical Devices

GLOBAL ELECTROCEUTICALS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiac Pacemakers & Implantable Cardioverter Defibrillators
  • Arrhythmia
  • Heart Failure
  • Other Cardiac Pacemaker & Icd Applications
  • Spinal Cord Stimulators
  • Chronic Pain
  • Failed Back Surgery Syndrome
  • Ischemia
  • Deep Brain Stimulators
  • Parkinson's Disease
  • Tremors
  • Depression
  • Other DBS Applications
  • Sacral Nerve Stimulators
  • Urine Incontinence
  • Fecal Incontinence
  • Vagus Nerve Stimulators
  • Epilepsy
  • Other VNS Applications
  • Gastric Electrical Stimulators
  • Gastroparesis
  • Obesity
  • Transcutaneous Electrical Nerve Stimulators
  • Treatment-Resistant Depression
  • Other TENS Application
  • Transcranial Magnetic Stimulators
  • Depression
  • Migraine
  • Respiratory Electrical Stimulators
  • Spinal Cord Injury
  • Trigeminal Nerve Stimulators
  • Attention-Deficit/Hyperactivity Disorder
  • Migraine

GLOBAL ELECTROCEUTICALS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Electroceuticals Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Electroceuticals Market Snippet by Product
    • 2.1.2. Electroceuticals Market Snippet by Type
    • 2.1.3. Electroceuticals Market Snippet by Application
    • 2.1.4. Electroceuticals Market Snippet by Country
    • 2.1.5. Electroceuticals Market Snippet by Region
  • 2.2. Competitive Insights

3. Electroceuticals Key Market Trends

  • 3.1. Electroceuticals Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Electroceuticals Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Electroceuticals Market Opportunities
  • 3.4. Electroceuticals Market Future Trends

4. Electroceuticals Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Electroceuticals Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Electroceuticals Market Landscape

  • 6.1. Electroceuticals Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Electroceuticals Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Cardiac Pacemakers & Implantable Cardioverter Defibrillators
    • 7.1.3. Cochlear Implants
    • 7.1.4. Neuromodulators
      • 7.1.4.1. Spinal Cord Stimulators
      • 7.1.4.2. Deep Brain Stimulators
      • 7.1.4.3. Vagus Nerve Stimulators
      • 7.1.4.4. Sacral Nerve Stimulators
      • 7.1.4.5. Gastric Electrical Stimulators
      • 7.1.4.6. Transcranial Magnetic Stimulators
      • 7.1.4.7. Respiratory Electrical Stimulators
      • 7.1.4.8. Trigeminal Nerve Stimulators
      • 7.1.4.9. Responsive Neurostimulators
    • 7.1.5. Retinal Implants

8. Electroceuticals Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 8.1.2. Implantable Electroceutical Devices
    • 8.1.3. Non-invasive Electroceutical Devices

9. Electroceuticals Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Cardiac Pacemakers & Implantable Cardioverter Defibrillators
      • 9.1.2.1. Arrhythmia
      • 9.1.2.2. Heart Failure
      • 9.1.2.3. Other Cardiac Pacemaker & Icd Applications
    • 9.1.3. Spinal Cord Stimulators
      • 9.1.3.1. Chronic Pain
      • 9.1.3.2. Failed Back Surgery Syndrome
      • 9.1.3.3. Ischemia
    • 9.1.4. Deep Brain Stimulators
      • 9.1.4.1. Parkinson's Disease
      • 9.1.4.2. Tremors
      • 9.1.4.3. Depression
      • 9.1.4.4. Other Dbs Applications
    • 9.1.5. Sacral Nerve Stimulators
      • 9.1.5.1. Urine Incontinence
      • 9.1.5.2. Fecal Incontinence
    • 9.1.6. Vagus Nerve Stimulators,
      • 9.1.6.1. Epilepsy
      • 9.1.6.2. Other Vns Applications
    • 9.1.7. Gastric Electrical Stimulators
      • 9.1.7.1. Gastroparesis
      • 9.1.7.2. Obesity
    • 9.1.8. Transcutaneous Electrical Nerve Stimulators
      • 9.1.8.1. Treatment-Resistant Depression
      • 9.1.8.2. Other Tens Application
    • 9.1.9. Transcranial Magnetic Stimulators
      • 9.1.9.1. Depression
      • 9.1.9.2. Migraine
    • 9.1.10. Respiratory Electrical Stimulators
      • 9.1.10.1. Spinal Cord Injury
    • 9.1.11. Trigeminal Nerve Stimulators
      • 9.1.11.1. Attention-Deficit/Hyperactivity Disorder
      • 9.1.11.2. Migraine

10. Electroceuticals Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Electroceuticals Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Electroceuticals Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Electroceuticals Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Electroceuticals Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Electroceuticals Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Electroceuticals Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Medtronic
    • 11.2.2. Boston Scientific Corporation
    • 11.2.3. Abbott
    • 11.2.4. Livanova Plc
    • 11.2.5. Cochlear Ltd.
    • 11.2.6. Microport Scientific Corporation
    • 11.2.7. Sonova
    • 11.2.8. Nervo Corp.
    • 11.2.9. Axonics Inc.
    • 11.2.10. Neuronetics
    • 11.2.11. Electrocore Inc.
    • 11.2.12. Neuropace Inc.
    • 11.2.13. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us